SCHEMBL26935975

SCHEMBL26935975

CC(C)(C)c1ccc2c(c1)nnn2CC(=O)N1CCCC1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.62
CYP2C9 P11712 1/20 0.62
CYP2C19 P33261 1/20 0.62
POLB P06746 2/20 0.47
SMN1; SMN2 Q16637 3/20 0.45
HTT P42858 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PKM P14618 1/20 0.43
HPGD P15428 3/20 0.43
HCAR3 P49019 2/20 0.40
CNR2 P34972 1/20 0.40
GRIN2B Q13224 2/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26935481 0.81 HPGD (0.51) POLBSMN1; SMN2HTTNPC1RAB9A
SCHEMBL18997056 0.74 HCAR3 (0.55) POLBNPC1RAB9APKMHCAR3
SCHEMBL26935472 0.73 PKM (0.42) SMN1; SMN2HTTNPSR1PKMHCAR3
SCHEMBL26777187 0.73 PKM (0.41) SMN1; SMN2HTTNPSR1PKMHCAR3
SCHEMBL10254346 0.66 HCAR3 (0.51) POLBSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL15317641 0.66 SMN1; SMN2 (0.61) POLBSMN1; SMN2HTTNPC1RAB9A
SCHEMBL19848262 0.65 PKM (0.52) GAAPOLBSMN1; SMN2HTTNPSR1
SCHEMBL21669989 0.65 HCAR3 (0.58) GAAPOLBMEN1ALDH1A1KMT2A
SCHEMBL14212249 0.64 MEN1 (0.74) GAACYP2C9CYP2C19POLBSMN1; SMN2
SCHEMBL16727316 0.64 CCNC (0.44) POLBSMN1; SMN2HTTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399332-A1 IMIDAZO[1,2-a]PYRAZINE OR PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND USE THEREOF TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED (CN) 2023-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399332-A1 IMIDAZO[1,2-a]PYRAZINE OR PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND USE THEREOF CYP2D6, UGT1A1, TPMT GAA 3428/4885CYP2C9 50/4885CYP2C19 74/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.